←Back to Expert Scholars
Translational Medicine / 转化医学Camelid Nanobodies
Serge Muyldermans
PhD
🏢Vrije Universiteit Brussel🌐Belgium
Professor
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Serge Muyldermans discovered and developed camelid single-domain antibodies (nanobodies/VHH) that enable compact therapeutic and imaging reagents for cancer. His lab provided foundational tools for nanobody-based CAR T cells, imaging agents, and drug conjugates.
Share:
🧪Research Fields 研究领域
nanobody VHH
camelid antibody
single domain antibody
nanobody engineering
caplacizumab
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Serge Muyldermans 的研究动态
Follow Serge Muyldermans's research updates
留下邮箱，当我们发布与 Serge Muyldermans（Vrije Universiteit Brussel）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment